Author

Barbara Cellini

University of PerugiaORCID 0000-0002-5221-9288Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 1 Assay:protein structure· 1

Frequent Co-Authors

Mirco DindoiD· 3 shared Angel Luis PeyiD· 2 shared Atanasio Gómez‐MulasiD· 1 shared Carolina ConteriD· 1 shared Dmitry S. LoginoviD· 1 shared EDUARDO C. SALIDOiD· 1 shared Francisco Conejero‐LaraiD· 1 shared Gen‐ichiro UechiiD· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

Mirco DindoORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Emergent Chemical Reactivity and Complexity of RNA Condensates

Samuel Hauf, Ryô Nakamura, Barbara Cellini, Yohei Yokobayashi, Mirco Dindo

This study investigates RNA condensates formed at acidic pH, showing they compartmentalize biomolecules, enhance reaction rates, and act as microreactors with catalytic activity, supporting the RNA world hypothesis.

Angewandte Chemie International Edition · Nov 10, 2025Peer-reviewedBiochemistry

Nanobodies as therapies for loss-of-function misfolding diseases.

Atanasio Gómez‐Mulas, Mirco Dindo, Juan Luis Pacheco‐García, Silvia Grottelli, Mario Cano‐Muñoz, Pavla Vaňková, Dmitry S. Loginov, EDUARDO C. SALIDO, Petr Man, Francisco Conejero‐Lara, Barbara Cellini, Angel Luis Pey

This study develops and characterizes six nanobodies as potential therapeutics for PH1 by targeting misfolded AGT variants, showing high affinity and functional enhancement in cellular models.

bioRxiv · Apr 12, 2025 · PreprintBiophysics

Engineered Oxalate decarboxylase boosts activity and stability for biological applications

Mirco Dindo, Carolina Conter, Gen‐ichiro Uechi, Gioena Pampalone, Luana Ruta, Angel Luis Pey, Luigia Rossi, Paola Laurino, Mauro Magnani, Barbara Cellini

This study engineers Oxalate decarboxylase to improve its activity and stability for medical applications in hyperoxaluria treatment.

ACS Omega · Mar 24, 2025Peer-reviewedBiochemistry